The Disconnect Is Growing
Celltrion Inc (068270 KS) 's Inflectra, a biosimilar to Johnson & Johnson (JNJ US) 's Remicade, had little impact on the critical U.S. market...
757 Views
Celltrion Healthcare IPO - Summary on Last Week's IPO Roadshow in HK & Singapore
Celltrion Healthcare just completed the pre-IPO roadshows in Hong Kong and Singapore last week. The company officials met about 15 institutional...
477 Views
Revisiting Samsung BioLogics at This Interesting Time
I don't really intend to make any investment recommendation on BioLogics at this point. I have to admit that I'm still feeling the current price is...
423 Views
Recent Developments Not Encouraging
This Insight provides an update on developments in the US market related to biosimilars, and are of great significance to Celltrion Inc (068270...
371 Views
Eubiologics IPO Part 3 - IPO Bookbuilding Results & Personal View
Eubiologics IPO price was set at ₩6,000, the lowest end of the indicative price band, after conducting the demand survey (bookbuilding) (Jan 9-10)...
629 Views